Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations

2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Saudi Arabia Generic Drugs Market Outlook
4.1. Market Size & Forecast
4.1.1. By Value
4.2. Market Share & Forecast
4.2.1. By Type (Small Molecule Generics, Biosimilars)
4.2.2. By Mode of Drug Delivery (Oral, Topical, Parenteral, Others)
4.2.3. By Form (Tablet, Capsule, Injection, Others)
4.2.4. By Source (In House, Contract Manufacturing Organizations)
4.2.5. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others)
4.2.6. By Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Anti-Inflammatory Diseases, Others)
4.2.7. By Region (Eastern, Western, Northern & Central, Southern)
4.2.8. By Company (2023)
4.3. Market Map

5. Saudi Arabia Small Molecule Generics Drugs Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Mode of Drug Delivery
5.2.2. By Form
5.2.3. By Source
5.2.4. By Distribution Channel
5.2.5. By Application

6. Saudi Arabia Biosimilars Generic Drugs Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Mode of Drug Delivery
6.2.2. By Form
6.2.3. By Source
6.2.4. By Distribution Channel
6.2.5. By Application

7. Market Dynamics
7.1. Drivers
7.2. Challenges

8. Market Trends & Developments
8.1. Recent Developments
8.2. Product Launches
8.3. Mergers & Acquisitions

9. Policy & Regulatory Landscape

10. Saudi Arabia Economic Profile

11. Competitive Landscape
11.1. Tabuk Pharmaceuticals Manufacturing Co.
11.1.1. Business Overview
11.1.2. Company Snapshot
11.1.3. Products & Services
11.1.4. Financials (As Reported)
11.1.5. Recent Developments
11.1.6. Key Personnel Details
11.2. SWOT Analysis
11.3. Jamjoom Pharmaceuticals Co.
11.4. Riyadh Pharma
11.5. Al Jazeera Pharmaceutical Industries Ltd (Hikma)
11.6. Pfizer Saudi Limited Corporate
11.7. Sanofi Aventis Arabia Co. Ltd.
11.8. Novartis (Saudi Arabia)
11.9. GlaxoSmithKline (Saudi Arabia)
11.10. Novo Nordisk (Saudi Arabia)

12. Strategic Recommendations

13. About Us & Disclaimer